Note for Press: For information including videos and medical documents related to the June 29th press announcement  entitled "Different Stem Cell Treatments Both Produce Results for Two Similar Patients in China" click here. 

Beike Biotechnology Company Limited is bio-technology company that was founded with capital from Beijing University, Hong Kong University of Science and Technology and Shenzhen City Hall. Its chairman is Dr. Sean Hu. It is also supported with funds from the China State National Fund. The research and clinical work comes as a collaboration of Beijing University, Hong Kong University of Science and Technology, No. 3 Army Medical University, Zhongshan Medical University, Guiyang Medical College and Zhengzhou University. They have over 60 Ph.D. researchers focusing on stem cell research throughout their labs.

Beike is a bio-technology company that was founded with capital from Beijing University, Hong Kong University of Science and Technology and Shenzhen City Hall. It is also supported with funds from the China State National Fund. The research and clinical work comes as a collaboration of Beijing University, Hong Kong University of Science and Technology, No. 3 Army Medical University, Zhongshan Medical University, Guiyang Medical College and Zhengzhou University. Throughout all collaborating laboratories, Beike has over 60 Ph.D. researchers focusing on stem cell research. The company was formed in January of 2005 after the collaborating scientists felt comfortable enough with their years of research and clinical experience to begin treating patients with stem cells on a commercial scale.

The management, researchers and doctors have been focused on stem cell and other biomedical research since 1999. They have been treating patients with stem cell injections since 2001. As of June 1st, 2005, Beike had treated over 800 patients with stem cell injections for diseases like Alzheimers, Ataxia, Autism, ALS, Brain Trauma, Cerebral Infarction, Cerebral Hemorrhage, Cerebral Palsy, Guillain-Barre, diabetic foot/arteriosclerosis, Encephalatropy, and Spinal Cord Injury. Beike currently supplies stem cells for treatment at hospitals in Chongqing, Shenyang, Qingdao, Shenzhen and Zhengzhou concentrating on using cord blood stem cells for treatment. The stem cells are delivered through IV, injections into the spinal cord fluid and surgical injections in some cases of spinal cord injury. Except in the case of some spinal cord injury treatments, the treatments are done as outpatient procedures. 

Beike’s main research labs are located in Shenyang, Zhengzhou and Shenzhen with support from scientists from all of the collaborative universities. Beike partners with the blood banks in each city that their labs reside in to certify their stem cells are pure and disease free. Beike employs a double check system which consists of their quality control technicians checking a second time for infectious diseases before beginning the cultivation process. In Shenzhen, their lab is at the Shenzhen Hi-tech Industrial Zone which is one of the five large industrial zones with key focus from the Chinese central Government. With the support of the Shenzhen City Hall and the Shen Zhen Hi-tech industrial zone, Beike has been able to develop extremely rapidly. Beike is one of the leading expert groups in China for separating purifying, nurturing, and multiplying embryonic, fetal, adult and most importantly – cord blood stem cells. Beike has been able to grow human organ cells as well which will pave the way for future cures.

Beike’s greatest strength and what differentiates it from other research initiatives is that Beike specializes in clinical applications. There are a lot of patients in countries around the world who could have a better quality of life and even extend their lives with the technology available but don’t have the chance because of politics, religion and bureaucracy. Beike’s goal is to help those people. Beike takes the most advanced biotechnological research in the world, specifically stem cell therapy, and applies it clinically at a rapid pace.  

“Tomorrow's Treatments Today” 

Beike treats foreign patients in Nan Shan Hospital in Shen Zhen which is just across the border from Hong Kong. Nan Shan is the biggest hospital in the Western part of Shen Zhen with over 1,200 beds and over 1,000 employees. Foreign Patients are cared for on the 19th floor of the hospital. The neurosurgery department has eleven doctors and modern medical facilities and equipment.